| Literature DB >> 28086793 |
Vivian Carolina Salgueiro1, Natalia Lopes Pontes Iorio2, Marcelle Cristina Ferreira1, Raiane Cardoso Chamon1, Kátia Regina Netto Dos Santos3.
Abstract
BACKGROUND: Staphylococcus epidermidis is an opportunistic pathogen involved in hospital-acquired infections, particularly in those related to medical devices. This study characterized 50 genetically unrelated S. epidermidis isolates from bloodstream infections (BSIs, n = 31) and nares (n = 19) of neonates in relation to staphylococcal chromosomal cassette mec (SCCmec) type, biofilm production and associated genes, and the arginine catabolic mobile elements (ACME), in order to detect virulence factors that could discriminate a potential invasiveness isolate or predict an increasing pathogenicity.Entities:
Keywords: Bloodstream infection; Nasal; Neonates; S. epidermidis; SCCmec; Virulence
Mesh:
Substances:
Year: 2017 PMID: 28086793 PMCID: PMC5237318 DOI: 10.1186/s12866-017-0930-9
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Dendrogram of the pulsed-field gel electrophoresis (PFGE) profiles of SmaI-digested genomic DNA of 50 genetically unrelated Staphylococcus epidermidis isolates and associated characteristics. Similarities percentage is identified on a dendrogram derived from the unweighted pair group method using arithmetic averages and based on Dice coefficients. a B: Bloodstream infection isolates, N: Nasal isolates; b (+++): strong; (++): moderate; (+): weak: (−): non-biofilm producer; c +: presence; −: absence; d I: arcA+/opp3AB+, II: arcA+/opp3AB-, III: arcA-/opp3AB+; −: negative; e −: not-detectable; na: not-applicable (methicillin-sensitive isolate); f na: not-applicable (methicillin-sensitive isolate); nt: non-typeable; g ST: sequence type; CC: clonal complex; S: singleton; NPF: none predicted founder
Genes, oligonucleotide primers and PCR conditions used in this study
| Protein or genetic element | Gene | Primers 5’ → 3’a | Amplicon size | PCR | References |
|---|---|---|---|---|---|
| Aae |
| F: GAGGAGGATTTTAAAGTGC | 858 | 94 °C, 3 min; 40 cycles of: 94 °C, 90s; 55 °C, 1 min; 72 °C, 90s; final extension 72 °C, 5 min. | [ |
| Aap |
| F: ATACAACTGGTGCAGATGGTTG | 400 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 50 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| AtlE |
| F: CAACTGCTCAACCGAGAACA | 682 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 62 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| Bhp |
| F: ACGGACAATATCGTCTCTCAA | 1917 | 94 °C, 2 min; 40 cycles of: 94 °C, 30s; 55 °C, 30s; 72 °C, 75 s; final extension 72 °C, 5 min. | [ |
| Embp |
| F: AGCGGTACAAATGTCAATATC | 455 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 62 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| GehD |
| F: TTTGAATTCTGCGCAAGCTCAATATAA | 1179 | 94 °C, 2 min; 30 cycles of: 94 °C, 30s; 55 °C, 30s; 72 °C, 75 s; final extension 72 °C, 5 min. | [ |
| SdrF |
| F: GCTGAAGACAATCAATTAG | 1875 | 94 °C, 4 min; 30 cycles of: 94 °C, 2 min; 60 °C, 1 min; 72 °C, 2 min; final extension 72 °C, 5 min. | [ |
| SdrG |
| F: TAAACACCGACGATAATAACCAAA | 496 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 62 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| SesI |
| F: GCTGATTATGTAAATGACTCAAAT | 408 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 50 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| IcaADB |
| F: TTATCAATG CCGCAGTTGTC | 546 | 94 °C, 3 min; 30 cycles of: 94 °C, 1 min; 58 °C, 1 min; 72 °C, 1 min; final extension 72 °C, 5 min. | [ |
| ACME |
| F: CTAACACTGAACCCCAATG | 1946 | 95 °C, 10 min; 30 cycles of: 94 °C, 1 min; 52 °C, 1 min; 72 °C, 2 min; final extension 72 °C, 5 min. | [ |
|
| F: GCAAATCTGTAAATGGTCTGTTC | 1183 |
a F: Forward; R: Reverse
b bp: base pairs
Virulence genes and biofilm production in 50 Staphylococcus epidermidis isolates from bloodstream infection and nasal colonization
| Biofilm-associated virulence | Number (%) of isolates | Number (%) of biofilm producer isolates | ||||
|---|---|---|---|---|---|---|
| BSIa
| Nasalb
|
| BSIa
| Nasalb
|
| |
|
| 31 (100) | 19 (100) | 1 | 8 (100) | 8 (100) | 1 |
|
| 18 (58) | 16 (84) | 0.068 | 7 (88) | 8 (100) | 1 |
|
| 30 (97) | 19 (100) | 1 | 8 (100) | 8 (100) | 1 |
|
| 1 (3) | 1 (5) | 1 | 0 (0) | 0 (0) | 1 |
|
| 28 (90) | 19 (100) | 0.279 | 8 (100) | 8 (100) | 1 |
|
| 23 (74) | 16 (84) | 0.498 | 7 (88) | 6 (75) | 1 |
|
| 23 (74) | 11 (58) | 0.349 | 6 (75) | 6 (75) | 1 |
|
| 20 (65) | 2 (11) | 0.001c | 6 (75) | 0 (0) | 0.007c |
|
| 12 (39) | 0 (0) | 0.02c | 3 (38) | 0 (0) | 0.2 |
|
| 14 (45) | 10 (53) | 0.772 | 6 (75) | 7 (88) | 0.6 |
|
| 6 (19) | 1 (5) | 0.229 | 4 (50) | 1(13) | 0.282 |
|
| 3 (10) | 1 (5) | 1 | 1 (13) | 1 (13) | 1 |
a BSI: Bloodstream infection isolates
b Nasal: Nasal isolates
c: results with statistical significance
Virulence genes profiles and SCCmec types identified among 50 Staphylococcus epidermidis isolates from bloodstream infection and nasal colonization
|
| Isolates | Biofilm-associated virulence genes c | SCC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( |
|
|
|
|
|
|
|
|
|
| ||
| BSI and Nasal | 6 (1B + 5 N) | + | + | + | + | - | + | + | + | - | - | V (1B + 2 N), nt1, nt3, nt7 |
| 4 (1B + 3 N) | - | + | + | + | - | + | + | + | - | - | IV (1B), nt1, nt10, na | |
| 3 (2B + 1 N) | - | + | + | + | - | + | + | - | - | - | IV (1B), nt3, na | |
| 3 (1B + 2 N) | + | + | + | + | - | + | + | - | - | - | nt3 (1B), nt1 (2 N) | |
| 2 (1B + 1 N) | - | + | - | + | - | + | + | + | - | - | IV (1B), nt3 | |
| 2 (1B + 1 N) | + | + | + | + | - | + | + | + | + | - | nt2 (1B), V | |
| 2 (1B + 1 N) | - | + | + | + | - | + | - | - | - | - | nt2 (1B), nt4 | |
| BSI | 4 | + | + | + | + | - | + | + | + | + | + | III, nt5, nt9, nt12 |
| 3 | - | + | + | + | - | + | + | + | + | + | IV (2), nt8 | |
| 2 | - | + | + | + | - | + | + | + | + | - | IV, na | |
| 1 | + | + | - | + | - | + | + | + | + | + | III | |
| 1 | - | + | + | + | - | + | + | + | - | + | IV | |
| 1 | + | + | - | + | - | + | + | + | + | - | IV | |
| 1 | - | + | - | + | - | + | + | + | + | + | IV | |
| 1 | + | + | - | + | - | + | - | + | - | - | V | |
| 1 | - | + | - | + | - | + | - | - | + | + | nt2 | |
| 1 | + | + | - | + | - | - | + | + | + | + | nt6 | |
| 1 | + | + | - | + | - | - | + | - | - | - | nt13 | |
| 1 | - | + | - | + | + | + | - | + | + | - | na | |
| 1 | - | + | - | + | - | + | - | + | - | - | nt1 | |
| 1 | - | + | - | + | - | + | - | + | + | - | nt1 | |
| 1 | + | + | + | + | - | + | + | - | + | - | nt11 | |
| 1 | - | + | - | - | - | - | - | + | + | - | na | |
| 1 | + | + | - | + | - | + | - | - | + | - | nt14 | |
| Nasal | 2 | - | + | - | + | - | + | + | - | - | - | nt1 |
| 1 | + | + | + | + | - | + | - | - | - | - | nt4 | |
| 1 | + | + | + | + | - | + | - | + | - | - | nt1 | |
| 1 | - | + | + | + | + | + | + | - | + | - | nt2 | |
a BSI: Bloodstream infection isolates
b B: Bloodstream infection isolates; N: Nasal isolates
c +: presence; -: absence
d III: mec complex A/ccr 3; IV: mec complex B/ccr 2; V: mec complex C/ccr 5; nt: non-typeable; na: not-applicable (methicillin-sensitive isolate); nt1: mec complex -/ccr -; nt2: mec complex -/ccr 2; nt3: mec complex C/ccr -; nt4: mec complex -/ccr 5; nt5: mec complex A/ccr -; nt6: mec complex A/ccr 3,4 and 5; nt7: mec complex B/ccr -; nt8: mec complex B/ccr 2 and 4; nt9: mec complex B/ccr 4 and 5; nt10: mec complex C/ccr 2 and 5; nt11: mec complex C/ccr 4 and 5; nt12: mec complex C/ccr 2,4 and 5; nt13: mec complex -/ccr 4; nt14: mec complex -/ccr 4 and 5